HHHBIO Trademark

Trademark Overview


On Friday, July 10, 2020, a trademark application was filed for HHHBIO with the United States Patent and Trademark Office. The USPTO has given the HHHBIO trademark a serial number of 79300811. The federal status of this trademark filing is REGISTERED as of Tuesday, June 29, 2021. This trademark is owned by 3H Bio. Co., Ltd.. The HHHBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drugs for medical purposes, namely, drugs for the treatment of oncological and metabolic diseases and disorders; medicines for human purposes, namely, medicine for the treatment of infectious diseases; medicines for human purposes, namely, medicine for the treatment of viral diseases and disorders; medicines for human purposes, namely, medicine for the treatment of respiratory diseases and disorders; therapeutic drugs and agents, namely, therapeutic drugs for the treatment of immune system related diseases and disorders; pharmaceutical preparations for preventing and treating obesity; vaccines; human vaccine preparations; pharmaceutical agents affecting metabolism; protein for medical purposes, namely, protein arrays for diagnosing cancer; protein for medical purposes, namely, protein arrays for diagnosing allergies; peptide for medical purposes, namely, synthetic peptides for the treatment of immune system related diseases and disorders; synthetic protein for the treatment of diabetes...

Research relating to pharmaceuticals, namely, pharmaceutical research services; medicine research, namely, research and development of medicines; medical analysis services of peptide for the treatment of people; research for medical products, namely medical research; chemical research; biological research; laboratory research in the field of pharmaceuticals; clinical studies of medicines, namely, conducting clinical trials for others; operation of medical laboratory, namely, medical laboratory services; scientific research for medical purposes; research and development of peptide for medical purposes; research of biology; research and development of peptide for scientific or laboratory purposes; drug discovery services; research and development of technology for biotechnology; development of pharmaceutical preparations and medicines
hhhbio

General Information


Serial Number79300811
Word MarkHHHBIO
Filing DateFriday, July 10, 2020
Status700 - REGISTERED
Status DateTuesday, June 29, 2021
Registration Number6399124
Registration DateTuesday, June 29, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements


Indication of Colors claimedThe color(s) green and red is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a stylized word "HHHBio" which consists of the three overlapped "H"s connected to "B" in green and "i" and "o" in red.
Goods and ServicesDrugs for medical purposes, namely, drugs for the treatment of oncological and metabolic diseases and disorders; medicines for human purposes, namely, medicine for the treatment of infectious diseases; medicines for human purposes, namely, medicine for the treatment of viral diseases and disorders; medicines for human purposes, namely, medicine for the treatment of respiratory diseases and disorders; therapeutic drugs and agents, namely, therapeutic drugs for the treatment of immune system related diseases and disorders; pharmaceutical preparations for preventing and treating obesity; vaccines; human vaccine preparations; pharmaceutical agents affecting metabolism; protein for medical purposes, namely, protein arrays for diagnosing cancer; protein for medical purposes, namely, protein arrays for diagnosing allergies; peptide for medical purposes, namely, synthetic peptides for the treatment of immune system related diseases and disorders; synthetic protein for the treatment of diabetes; synthetic protein for the treatment of oncological and metabolic diseases and disorders; synthetic peptide for the treatment of obesity; synthetic peptide for the treatment of viral diseases and disorders; pharmaceutical preparations containing peptides as the active ingredients, namely, pharmaceutical preparations for the treatment of neurological diseases and disorders
Goods and ServicesResearch relating to pharmaceuticals, namely, pharmaceutical research services; medicine research, namely, research and development of medicines; medical analysis services of peptide for the treatment of people; research for medical products, namely medical research; chemical research; biological research; laboratory research in the field of pharmaceuticals; clinical studies of medicines, namely, conducting clinical trials for others; operation of medical laboratory, namely, medical laboratory services; scientific research for medical purposes; research and development of peptide for medical purposes; research of biology; research and development of peptide for scientific or laboratory purposes; drug discovery services; research and development of technology for biotechnology; development of pharmaceutical preparations and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Name3H Bio. Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressKR

Party Name3H Bio. Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKR

Party Name3H Bio. Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, November 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 28, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 28, 2021FINAL DISPOSITION PROCESSED
Wednesday, September 29, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 29, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 13, 2021NOTIFICATION PROCESSED BY IB
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 1, 2021REFUSAL PROCESSED BY IB
Friday, February 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 5, 2021REFUSAL PROCESSED BY MPU
Wednesday, January 20, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 19, 2021NON-FINAL ACTION WRITTEN
Saturday, January 16, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Tuesday, January 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 11, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB